February 2024
1. MAGNO S, Ceccarini G, Corvillo F, Pelosini C, et al
   Clinical Characteristics of Patients With Acquired Partial Lipodystrophy: A Multicenter Retrospective Study.
   J Clin Endocrinol Metab. 2024;109:e932-e944.
   

   >> Share

   
   
2. HEDEGAARD BS, Nordestgaard BG, Kanstrup HL, Thomsen KK, et al
   High Lipoprotein(a) May Explain One-Quarter of Clinical Familial Hypercholesterolemia Diagnoses in Danish Lipid Clinics.
   J Clin Endocrinol Metab. 2024;109:659-667.
   

   >> Share

   
   
3. BESCI O, Foss de Freitas MC, Guidorizzi NR, Guler MC, et al
   Deciphering the Clinical Presentations in LMNA-related Lipodystrophy: Report of 115 Cases and a Systematic Review.
   J Clin Endocrinol Metab. 2024;109:e1204-e1224.
   

   >> Share

   
   
4. U-DIN M, Ahmed BA, Syed SA, Ong FJ, et al
   Characteristics of Abdominal Visceral Adipose Tissue, Metabolic Health and the Gut Microbiome in Adults.
   J Clin Endocrinol Metab. 2024;109:680-690.
   

   >> Share

   
   December 2023
5. ALVAREZ-JIMENEZ L, Morales-Palomo F, Moreno-Cabanas A, Ortega JF, et al
   Acute Statin Withdrawal Does not Interfere With the Improvements of a Session of Exercise in Postprandial Metabolism.
   J Clin Endocrinol Metab. 2023;109:80-91.
   

   >> Share

   
   November 2023
6. LI S, Cui M, Liu Y, Liu X, et al
   Metabolic profiles of type 2 diabetes and their association with renal complications.
   J Clin Endocrinol Metab. 2023 Nov 2:dgad643. doi: 10.1210.
   

   >> Share

   
   September 2023
7. MEYER EJ, Wittert GA
   Approach the patient with obstructive sleep apnea and obesity.
   J Clin Endocrinol Metab. 2023 Sep 27:dgad572. doi: 10.1210.
   

   >> Share

   
   
8. TAO X, Liu L, Ma P, Hu J, et al
   Association of Circulating Very Long Chain Saturated Fatty Acids with Cardiovascular Mortality in NHANES 2015-2016.
   J Clin Endocrinol Metab. 2023 Sep 21:dgad561. doi: 10.1210.
   

   >> Share

   
   July 2023
9. CHEN JX, Geng T, Zhang YB, Wang Y, et al
   Associations of Clinical Risk Factors and Novel Biomarkers with Age at Onset of Type 2 Diabetes.
   J Clin Endocrinol Metab. 2023 Jul 15:dgad422. doi: 10.1210.
   

   >> Share

   
   May 2023
10. GRIGORYAN S, Nhan W, Zhang L, Urban C, et al
    Rates of Pheochromocytoma/Paraganglioma Screening in At-Risk Populations.
    J Clin Endocrinol Metab. 2023;108:e343-e349.
    

    >> Share

    
    April 2023
11. SYED-ABDUL MM, Stahel P, Zembroski A, Tian L, et al
    Glucagon-like Peptide-2 Acutely Enhances Chylomicron Secretion in Humans Without Mobilizing Cytoplasmic Lipid Droplets.
    J Clin Endocrinol Metab. 2023;108:1084-1092.
    

    >> Share

    
    March 2023
12. NEWMAN CB, Tobert JA
    Targeting PCSK9 With Antibodies and Gene Silencing to Reduce LDL Cholesterol.
    J Clin Endocrinol Metab. 2023;108:784-790.
    

    >> Share

    
    February 2023
13. DIMAKOPOULOU A, Clarke SA, Jayasena CN
    Screening for Adverse Metabolic Consequences in Women With Idiopathic Hirsutism-Is it Relevant?
    J Clin Endocrinol Metab. 2023;108:e38-e39.
    

    >> Share

    
    January 2023
14. HORI M, Takahashi A, Hosoda K, Ogura M, et al
    A Low-Frequency APOB p.(Pro955Ser) Variant Contributes to the Severity of/Variability in Familial Hypercholesterolemia.
    J Clin Endocrinol Metab. 2023;108:422-432.
    

    >> Share

    
    December 2022
15. BRIL F, Pearce RW, Collier TS, McPhaul MJ, et al
    Differences in HDL-Bound Apolipoproteins in Patients With Advanced Liver Fibrosis Due to Nonalcoholic Fatty Liver Disease.
    J Clin Endocrinol Metab. 2022;108:42-51.
    

    >> Share

    
    
16. LIU Z, Tian Z, Zhao D, Liang Y, et al
    Effects of Coenzyme Q10 Supplementation on Lipid Profiles in Adults: A Meta-analysis of Randomized Controlled Trials.
    J Clin Endocrinol Metab. 2022;108:232-249.
    

    >> Share

    
    
17. PAQUETTE M, Bernard S, Baass A
    Dysbetalipoproteinemia Is Associated With Increased Risk of Coronary and Peripheral Vascular Disease.
    J Clin Endocrinol Metab. 2022;108:184-190.
    

    >> Share

    
    October 2022
18. VADMAND AC, Nissen AA, Mathiesen S, Ebbesen MS, et al
    Metabolic Dysregulation in Adult Survivors of Pediatric Hematopoietic Stem Cell Transplantation: The Role of Incretins.
    J Clin Endocrinol Metab. 2022 Oct 1. pii: 6743059. doi: 10.1210.
    

    >> Share

    
    September 2022
19. VALENTINE A, Davis S, Furniss A, Dowshen N, et al
    Multicenter Analysis of Cardiometabolic-related Diagnoses in Transgender and Gender-Diverse Youth: A PEDSnet Study.
    J Clin Endocrinol Metab. 2022;107:e4004-e4014.
    

    >> Share

    
    
20. SUN H, Zhu W, Liu J, An Y, et al
    Reduced sensitivity to thyroid hormones is associated with high remnant cholesterol levels in Chinese euthyroid adults.
    J Clin Endocrinol Metab. 2022 Sep 8. pii: 6693885. doi: 10.1210.
    

    >> Share

    
    August 2022
21. COSTA S, Sampaio L, Berta Sousa A, Xing C, et al
    Face-sparing Congenital Generalized Lipodystrophy Type 1 Associated With Nonclassical Congenital Adrenal Hyperplasia.
    J Clin Endocrinol Metab. 2022;107:2433-2438.
    

    >> Share

    
    July 2022
22. CAI X, Liang N, Cai X, Zhou Q, et al
    Lipid Metabolic Genes and Maternal Supraphysiological Hypercholesterolemia: An Analysis of Maternal-fetal Interaction.
    J Clin Endocrinol Metab. 2022;107:e3134-e3144.
    

    >> Share

    
    
23. SHANNON CE, Merovci A, Fourcaudot M, Tripathy D, et al
    Effects of Sustained Hyperglycemia on Skeletal Muscle Lipids in Healthy Subjects.
    J Clin Endocrinol Metab. 2022;107:e3177-e3185.
    

    >> Share

    
    
24. OSTINELLI G, Laforest S, Denham SG, Gauthier MF, et al
    Increased Adipose Tissue Indices of Androgen Catabolism and Aromatization in Women With Metabolic Dysfunction.
    J Clin Endocrinol Metab. 2022;107:e3330-e3342.
    

    >> Share

    
    June 2022
25. DING X, Wang Y, Liu J, Wang G, et al
    Impaired sensitivity to thyroid hormones is associated with elevated homocysteine levels in the euthyroid population.
    J Clin Endocrinol Metab. 2022 Jun 16. pii: 6609259. doi: 10.1210.
    

    >> Share

    
    May 2022
26. MELA V, Ruiz-Limon P, Balongo M, Rad HM, et al
    Mitochondrial Homeostasis In Obesity Related Hypertriglyceridemia.
    J Clin Endocrinol Metab. 2022 May 24. pii: 6591321. doi: 10.1210.
    

    >> Share

    
    
27. SUBRAMANIAN S
    Approach to the Patient With Moderate Hypertriglyceridemia.
    J Clin Endocrinol Metab. 2022;107:1686-1697.
    

    >> Share

    
    
28. FOURMAN LT, Grinspoon SK
    Approach to the Patient With Lipodystrophy.
    J Clin Endocrinol Metab. 2022;107:1714-1726.
    

    >> Share

    
    April 2022
29. DAVIS SM, Nokoff NJ, Furniss A, Pyle L, et al
    Population-based Assessment of Cardiometabolic-related Diagnoses in Youth With Klinefelter Syndrome: A PEDSnet Study.
    J Clin Endocrinol Metab. 2022;107:e1850-e1859.
    

    >> Share

    
    
30. WANG M, Xue Q, Li X, Krohn K, et al
    Circulating Levels of microRNA-122 and Hepatic Fat Change in Response to Weight-Loss Interventions: CENTRAL Trial.
    J Clin Endocrinol Metab. 2022;107:e1899-e1906.
    

    >> Share

    
    
31. AGUILAR-SALINAS CA, Gomez-Diaz RA, Corral P
    New Therapies for Primary Hyperlipidemia.
    J Clin Endocrinol Metab. 2022;107:1216-1224.
    

    >> Share

    
    March 2022
32. GUO K, Savelieff MG, Rumora AE, Alakwaa FM, et al
    Plasma Metabolomics and Lipidomics Differentiate Obese Individuals by Peripheral Neuropathy Status.
    J Clin Endocrinol Metab. 2022;107:1091-1109.
    

    >> Share

    
    
33. ZHANG S, Cheng S, He X, Wang W, et al
    Remnant Lipoprotein Cholesterol as a Factor Related to Adult Fatty Liver Disease.
    J Clin Endocrinol Metab. 2022;107:e1598-e1609.
    

    >> Share

    
    
34. EID WE, Sapp EH, Wendt A, Lumpp A, et al
    Improving Familial Hypercholesterolemia Diagnosis Using an EMR-based Hybrid Diagnostic Model.
    J Clin Endocrinol Metab. 2022;107:1078-1090.
    

    >> Share

    
    
35. CHUNG ST, Katz LEL, Stettler-Davis N, Shults J, et al
    The relationship between lipoproteins and insulin sensitivity in youth with obesity and abnormal glucose tolerance.
    J Clin Endocrinol Metab. 2022 Mar 3. pii: 6542083. doi: 10.1210.
    

    >> Share

    
    February 2022
36. STINSON SE, Jonsson AE, Fernandez de Retana Alzola I, Lund MAV, et al
    Hyperglucagonemia in pediatric adiposity associates with cardiometabolic risk factors but not hyperglycemia.
    J Clin Endocrinol Metab. 2022 Feb 25. pii: 6537120. doi: 10.1210.
    

    >> Share

    
    
37. MESAS AE, Garrido-Miguel M, Fernandez-Rodriguez R, Fernandez Franco S, et al
    Egg Consumption and Blood Lipid Parameters According to the Presence of Chronic Metabolic Disorders: The EVIDENT II Study.
    J Clin Endocrinol Metab. 2022;107:e963-e972.
    

    >> Share

    
    
38. OSUNA-PRIETO FJ, Rubio-Lopez J, Di X, Yang W, et al
    Plasma Levels of Bile Acids Are Related to Cardiometabolic Risk Factors in Young Adults.
    J Clin Endocrinol Metab. 2022;107:715-723.
    

    >> Share

    
    January 2022
39. PAQUETTE M, Bernard S, Pare G, Baass A, et al
    Dysbetalipoproteinemia: Differentiating Multifactorial Remnant Cholesterol Disease From Genetic ApoE Deficiency.
    J Clin Endocrinol Metab. 2022;107:538-548.
    

    >> Share

    
    
40. YANG R, Xu A, Kharitonenkov A
    Another Kid on the Block: Long-acting FGF21 Analogue to Treat Dyslipidemia and Fatty Liver.
    J Clin Endocrinol Metab. 2022;107:e417-e419.
    

    >> Share

    
    
41. RADER DJ, Maratos-Flier E, Nguyen A, Hom D, et al
    LLF580, an FGF21 Analog, Reduces Triglycerides and Hepatic Fat in Obese Adults With Modest Hypertriglyceridemia.
    J Clin Endocrinol Metab. 2022;107:e57-e70.
    

    >> Share

    
    December 2021
42. MOUSA A, Huynh K, Ellery SJ, Strauss BJ, et al
    Novel lipidomic signature associated with metabolic risk in women with and without polycystic ovary syndrome.
    J Clin Endocrinol Metab. 2021 Dec 31. pii: 6491229. doi: 10.1210.
    

    >> Share

    
    
43. HA J, Park SH, Park SS, Han S, et al
    Metabolic disease incidence after allogeneic stem cell transplantation: A Korean, nationwide, case-control study.
    J Clin Endocrinol Metab. 2021 Dec 14. pii: 6461117. doi: 10.1210.
    

    >> Share

    
    November 2021
44. HERRERO-AGUAYO V, Saez-Martinez P, Lopez-Canovas JL, Prados-Carmona JJ, et al
    Dysregulation of Components of the Inflammasome Machinery After Bariatric Surgery: Novel Targets for a Chronic Disease.
    J Clin Endocrinol Metab. 2021;106:e4917-e4934.
    

    >> Share

    
    
45. ASHRAF AP, Sunil B, Bamba V, Breidbart E, et al
    Case Studies in Pediatric Lipid Disorders and Their Management.
    J Clin Endocrinol Metab. 2021;106:3605-3620.
    

    >> Share

    
    October 2021
46. COHEN CC, Perng W, Sundaram SS, Scherzinger A, et al
    Hepatic Fat in Early Childhood Is Independently Associated With Estimated Insulin Resistance: The Healthy Start Study.
    J Clin Endocrinol Metab. 2021;106:3140-3150.
    

    >> Share

    
    
47. NGUYEN ML, Sachdev V, Burklow TR, Li W, et al
    Leptin Attenuates Cardiac Hypertrophy in Patients With Generalized Lipodystrophy.
    J Clin Endocrinol Metab. 2021;106:e4327-e4339.
    

    >> Share

    
    
48. TSABAN G, Yaskolka Meir A, Zelicha H, Rinott E, et al
    Diet-induced fasting ghrelin elevation reflects the recovery of insulin sensitivity and visceral adiposity regression.
    J Clin Endocrinol Metab. 2021 Oct 13. pii: 6382201. doi: 10.1210.
    

    >> Share

    
    September 2021
49. AGUILAR-RAMIREZ D, Alegre-Diaz J, Herrington WG, Staplin N, et al
    Association of Kidney Function With NMR-Quantified Lipids, Lipoproteins, and Metabolic Measures in Mexican Adults.
    J Clin Endocrinol Metab. 2021;106:2828-2839.
    

    >> Share

    
    August 2021
50. WANG J, Wang Z, Guo F, Zhang Y, et al
    Individual and combined cardiometabolic morbidities and the subsequent risk of cardiovascular events in Chinese adults.
    J Clin Endocrinol Metab. 2021 Aug 24. pii: 6357056. doi: 10.1210.
    

    >> Share

    
    
51. PAQUETTE M, Amyot J, Fantino M, Baass A, et al
    Rare Variants in Triglycerides-Related Genes Increase Pancreatitis Risk in Multifactorial Chylomicronemia Syndrome.
    J Clin Endocrinol Metab. 2021;106:e3473-e3482.
    

    >> Share

    
    July 2021
52. YU D, Wang Z, Zhang X, Qu B, et al
    Remnant cholesterol and cardiovascular mortality in patients with type 2 diabetes and incident diabetic nephropathy.
    J Clin Endocrinol Metab. 2021 Jul 22. pii: 6325383. doi: 10.1210.
    

    >> Share

    
    June 2021
53. MIYAMURA K, Nawa N, Isumi A, Doi S, et al
    The Association of Passive Smoking and Dyslipidemia Among Adolescence in Japan: Results From A-CHILD Study.
    J Clin Endocrinol Metab. 2021;106:e2738-e2748.
    

    >> Share

    
    April 2021
54. KIYA M, Tamura Y, Takeno K, Someya Y, et al
    Adipose Insulin Resistance and Decreased Adiponectin Are Correlated With Metabolic Abnormalities in Nonobese Men.
    J Clin Endocrinol Metab. 2021;106:e2228-e2238.
    

    >> Share

    
    March 2021
55. BELHASSEN M, Van Ganse E, Nolin M, Berard M, et al
    10-Year Comparative Follow-up of Familial versus Multifactorial Chylomicronemia Syndromes.
    J Clin Endocrinol Metab. 2021;106:e1332-e1342.
    

    >> Share

    
    
56. GRANT LK, Czeisler CA, Lockley SW, Rahman SA, et al
    Time-of-day and Meal Size Effects on Clinical Lipid Markers.
    J Clin Endocrinol Metab. 2021;106:e1373-e1379.
    

    >> Share

    
    
57. YEN CL, Fan PC, Lin MS, Lee CC, et al
    Fenofibrate Delays the Need for Dialysis and Reduces Cardiovascular Risk among Patients with Advanced CKD.
    J Clin Endocrinol Metab. 2021 Mar 2. pii: 6156972. doi: 10.1210.
    

    >> Share

    
    
58. MORYS F, Dadar M, Dagher A
    Association between mid-life obesity, its metabolic consequences, cerebrovascular disease and cognitive decline.
    J Clin Endocrinol Metab. 2021 Mar 2. pii: 6156963. doi: 10.1210.
    

    >> Share

    
    
59. TORKY A, Sinaii N, Jha S, Desai J, et al
    Cardiovascular Disease Risk Factors and Metabolic Morbidity in a Longitudinal Study of Congenital Adrenal Hyperplasia.
    J Clin Endocrinol Metab. 2021 Mar 2. pii: 6156969. doi: 10.1210.
    

    >> Share

    
    February 2021
60. STINSON SE, Jonsson AE, Lund MAV, Frithioff-Bojsoe C, et al
    Fasting plasma GLP-1 associates with overweight/obesity and cardiometabolic risk factors in children and adolescents.
    J Clin Endocrinol Metab. 2021 Feb 17. pii: 6141463. doi: 10.1210.
    

    >> Share

    
    
61. NGAOSUWAN K, Johnston DG, Godsland IF, Cox J, et al
    Cardiovascular disease in patients with primary and secondary adrenal insufficiency and the role of comorbidities.
    J Clin Endocrinol Metab. 2021 Feb 15. pii: 6135110. doi: 10.1210.
    

    >> Share

    
    
62. MORAN C, McEniery CM, Schoenmakers N, Mitchell C, et al
    Dyslipidemia, insulin resistance, ectopic lipid accumulation and vascular function in Resistance to Thyroid Hormone beta.
    J Clin Endocrinol Metab. 2021 Feb 1. pii: 6125725. doi: 10.1210.
    

    >> Share

    
    January 2021
63. LUUKKONEN PK, Qadri S, Lehtimaki TE, Juuti A, et al
    The PNPLA3-I148M Variant Confers an Antiatherogenic Lipid Profile in Insulin-resistant Patients.
    J Clin Endocrinol Metab. 2021;106:e300-e315.
    

    >> Share

    
    December 2020
64. NEWMAN CB, Blaha MJ, Boord JB, Cariou B, et al
    Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline.
    J Clin Endocrinol Metab. 2020;105.
    

    >> Share

    
    October 2020
65. FERCHAUD-ROUCHER V, Zair Y, Aguesse A, Krempf M, et al
    Omega 3 Improves Both apoB100-containing Lipoprotein Turnover and their Sphingolipid Profile in Hypertriglyceridemia.
    J Clin Endocrinol Metab. 2020;105.
    

    >> Share

    
    September 2020
66. KOTWAL A, Cortes T, Genere N, Hamidi O, et al
    Treatment of Thyroid Dysfunction and Serum Lipids: A Systematic Review and Meta-Analysis.
    J Clin Endocrinol Metab. 2020 Sep 21. pii: 5909289. doi: 10.1210.
    

    >> Share

    
    May 2020
67. KOZAKOVA M, Morizzo C, Penno G, Shore AC, et al
    Plasma Homocysteine and Cardiovascular Organ Damage in a Population with a High Prevalence of Risk Factors.
    J Clin Endocrinol Metab. 2020 May 26. pii: 5846189. doi: 10.1210.
    

    >> Share

    
    April 2020
68. MORALES-PALOMO F, Ramirez-Jimenez M, Ortega JF, Moreno-Cabanas A, et al
    Exercise Training Adaptations in Metabolic Syndrome Individuals on Chronic Statin Treatment.
    J Clin Endocrinol Metab. 2020;105.
    

    >> Share

    
    
69. LANGSTED A, Jensen AMR, Varbo A, Nordestgaard BG, et al
    Low High-Density Lipoprotein Cholesterol to Monitor Long-Term Average Increased Triglycerides.
    J Clin Endocrinol Metab. 2020;105.
    

    >> Share

    
    March 2020
70. FANG S, Zhang S, Huang Y, Wu Y, et al
    Evidence for associations between Th1/Th17 "hybrid" phenotype and altered lipometabolism in very severe Graves' orbitopathy.
    J Clin Endocrinol Metab. 2020 Mar 16. pii: 5805506. doi: 10.1210.
    

    >> Share

    
    
71. HSIUNG CN, Chang YC, Lin CW, Chang CW, et al
    The Causal Relationship of Circulating Triglyceride and Glycated Hemoglobin: A Mendelian Randomization Study.
    J Clin Endocrinol Metab. 2020;105.
    

    >> Share

    
    January 2020
72. KELSEY MM, Pyle L, Hilkin A, Severn CD, et al
    The impact of obesity on insulin sensitivity and secretion during pubertal progression: a longitudinal study.
    J Clin Endocrinol Metab. 2020 Jan 30. pii: 5717690. doi: 10.1210.
    

    >> Share

    
    
73. SHAH VN, Bailey R, Wu M, Foster NC, et al
    Risk Factors for Cardiovascular Disease (CVD) in Adults with Type 1 Diabetes: Findings from Prospective Real-life T1D Exchange Registry.
    J Clin Endocrinol Metab. 2020 Jan 19. pii: 5709622. doi: 10.1210.
    

    >> Share

    
    December 2019
74. HIGGINS V, Omidi A, Tahmasebi H, Asgari S, et al
    Marked influence of adiposity on laboratory biomarkers in a healthy cohort of children and adolescents.
    J Clin Endocrinol Metab. 2019 Dec 17. pii: 5675353. doi: 10.1210.
    

    >> Share

    
    
75. HIGGINS V, Asgari S, Hamilton JK, Wolska A, et al
    Postprandial dyslipidemia, hyperinsulinemia, and impaired gut peptides/bile acids in adolescents with obesity.
    J Clin Endocrinol Metab. 2019 Dec 11. pii: 5673404. doi: 10.1210.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share